KMTS (Kestra Medical Technologies) Other Income (Expense): $2.62 Mil (TTM As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KMTS Kestra Medical Technologies Ltd KMTS
12 GF Score
Price $25.13
! 6 Warning Signs
View Full Analysis

What is Kestra Medical Technologies Other Income (Expense)?

Kestra Medical Technologies KMTS -2.14% 12 Other Income (Expense) is $2.62 Mil as of Apr. 2026. GuruFocus rates KMTS with a GF Score™ of 12/100. The stock has 6 warning signs investors should review.

Kestra Medical Technologies's other income expense for the Kestra Medical Technologies's pretax income for the three months ended in Apr. 2026 was $0.32 Mil. Its other income expense for the trailing twelve months (TTM) ended in Apr. 2026 was $2.62 Mil.

Kestra Medical Technologies  (NAS:KMTS) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Kestra Medical Technologies Other Income (Expense) Historical Data

* Premium members only.

The historical data trend for Kestra Medical Technologies's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kestra Medical Technologies Other Income (Expense) Chart

Kestra Medical Technologies Annual Data
Trend Apr20 Apr21 Apr23 Apr24 Apr25 Apr26
Other Income (Expense)
Get a 7-Day Free Trial -0.04 1.83 -2.80 -2.77 2.62

Kestra Medical Technologies Quarterly Data
Apr20 Jul20 Apr21 Jul21 Apr23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.69 2.83 -0.89 0.36 0.32
KMTS
12GF Score
Kestra Medical Technologies Ltd KMTS
Other Income (Expense) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kestra Medical Technologies Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.62 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Income (Expense) →
What does a Other Income (Expense) of $2.62 Mil mean?
Kestra Medical Technologies (KMTS) has a Other Income (Expense) of $2.62 Mil as of Apr. 2026. Other income and expenses that a company records on the income statement. View historical data on Kestra Medical Technologies and its competitors.
Is Kestra Medical Technologies' Other Income (Expense) too high?
Kestra Medical Technologies' current Other Income (Expense) is $2.62 Mil. Overall, Kestra Medical Technologies has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Kestra Medical Technologies' Other Income (Expense) compare to AZTA and BLFS?
Kestra Medical Technologies' Other Income (Expense) of $2.62 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Income (Expense) for a Medical Devices & Instruments company?
A good Other Income (Expense) depends on the Medical Devices & Instruments industry context. However, Other Income (Expense) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Income (Expense) mean?
A high Other Income (Expense) can signal that a stock is expensive relative to its fundamentals. Other income and expenses that a company records on the income statement. View historical data on Kestra Medical Technologies and its competitors. Kestra Medical Technologies's current Other Income (Expense) is $2.62 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kestra Medical Technologies stock overvalued right now?
Kestra Medical Technologies (KMTS) has a current Other Income (Expense) of $2.62 Mil. The current Other Income (Expense) is $2.62 Mil. Kestra Medical Technologies' overall GF Score™ is 12/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Income (Expense) calculated?
Other Income (Expense) is calculated from a company's financial statements. For Kestra Medical Technologies (KMTS), the current Other Income (Expense) is $2.62 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kestra Medical Technologies Business Description

Address 3933 Lake Washington Boulevard NE, Suite 200, Kirkland, WA, USA, 98033
Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.
12GF Score

Get the complete analysis for KMTS

Other Income (Expense) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.13
Price